Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2019-04-10
2021-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group (D)
Patient will receive opioid only for management of their perioperative pain
IV morphine
given when VAS\>3
Paravertebral block Group (A)
Will receive thoracic paravertebral block
Ultrasound guided block
Giving one regional block
IV morphine
given when VAS\>3
Pectoral block Group (B)
Will receive pectoral 1 and 2 block
Ultrasound guided block
Giving one regional block
IV morphine
given when VAS\>3
Erector spinae block Group (C)
Will receive erector spinae block
Ultrasound guided block
Giving one regional block
IV morphine
given when VAS\>3
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound guided block
Giving one regional block
IV morphine
given when VAS\>3
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age group 18 - 60 years of the female gender
3. Patients undergoing breast cancer surgeries
Exclusion Criteria
2. History of hypersensitivity to local anesthetics
3. Bleeding disorders or patients receiving anticoagulants
4. Spine or chest wall deformities
5. Pregnancy
6. Local infection at the site of injection.
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menoufia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
kareem Mikhamer
Assistant fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
kareem M mikhimer, m.sc
Role: PRINCIPAL_INVESTIGATOR
assistant fellow, Ahmed Maher Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Menofia University
Shibīn al Kawm, Menofia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
32900654326
Identifier Type: -
Identifier Source: org_study_id